The latest version of Abbott's FreeStyle Libre continuous glucose ... scanned of 'flash' CGM if it is available for the same or lower acquisition cost, according to the draft, which is due to ...
2d
Zacks Investment Research on MSNEPD Expansion Supports Abbot Stock, Macro Issues PrevailAbbott's ABT diversified business portfolio is well-positioned to drive momentum. However, the international business ...
New research has examined how accurate continuous glucose monitors (CGM) are in comparison to capillary blood glucose measurements (CBGMs). The study has found that CGM can overestimate both fasting ...
Its most important segment, though, remains diabetes care where it markets the FreeStyle Libre, one of the leading franchises of continuous glucose monitoring (CGM) systems on the market.
DexCom said that on Tuesday it received a warning letter from the U.S. FDA following inspections at its facilities in San Diego, Calif., and Mesa, Ariz. related to concerns about manufacturing ...
The FDA cited issues with DexCom’s response to prior inspection findings, known as Form 483 observations. The inspections took place at the San Diego facility between October 21 and November 7, 2024, ...
New York, United States — US President Donald Trump signed an executive order Thursday establishing a “Strategic Bitcoin Reserve,” forcefully endorsing a currency once shunned as a tool for ...
Retatrutide is an new drug that has shown promise in the treatment of obesity and type 2 diabetes. Retatrutide is a type of multi-receptor agonist that targets multiple hormonal pathways involved in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results